基因敲除
癌症研究
小RNA
上皮-间质转换
生物
下调和上调
细胞
人口
表型
基因
抗药性
调节器
基因表达
小干扰RNA
细胞培养
癌症
转移
基底细胞
鳞癌
基因表达调控
边居
信号转导
差动显示
癌细胞
激酶
细胞生物学
单细胞分析
细胞生长
癌
细胞迁移
表皮样癌
间充质干细胞
过渡(遗传学)
信使核糖核酸
药品
核糖核酸
突变
作者
Abinash Behera,Sudeshna Datta,Sibasish Mohanty,Pallavi Mohapatra,Shamima Azma Ansari,Sreeparna Podder,R N Rath,Dillip Kumar Muduly,Rajeeb Kumar Swain,Sunil K. Raghav,Rupesh Dash
标识
DOI:10.1016/j.jbc.2025.111126
摘要
Despite initial positive responses with chemotherapy, many cancer patients experience relapse, continued tumor growth, and metastatic spread due to drug resistance. It is well documented that a rare population of phenotypically heterogeneous cells contributes to intratumour heterogeneity and drug resistance. To date, these rare populations are poorly characterized. To identify the potential role of these rare populations in drug resistance, here we have performed single-cell RNA sequencing of human oral squamous cell carcinomas lines presenting with sensitive, early, and late cisplatin-resistance patterns. The single-cell RNA-sequencing data identified two different transitional clusters within the three, sensitive, early, and late cisplatin-resistant major clusters. The differential gene expression profile and deregulated pathways analysis suggested Brain Abundant Membrane-Attached Signal Protein 1 (BASP1) as a major upregulated gene not only in major drug-resistant clusters but also in transitional clusters. Selective knockdown of BASP1 reverses epithelial to mesenchymal transition (EMT) phenotype in cisplatin-resistant cells and restores cisplatin-induced cell death. Mechanistically, BASP1 positively regulates LIN7A expression through phosphorylation of RAC-alpha serine/threonine-protein kinase as well as by supressing microRNA hsa-mir-501-3p, which in turn induces β-catenin-mediated EMT in chemoresistant cells. Overall, our study demonstrates that BASP1 acts as a key regulator of EMT in cisplatin-resistant oral squamous cell carcinoma and represents a promising therapeutic target to overcome drug resistance in advanced stages of the disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI